Breakthrough infections twice as likely to be asymptomatic
September 1, 2021
New research found that of 1.2 million adults who received at least one dose of either the Pfizer, Moderna, or AstraZeneca vaccine, fewer than 0.5% tested positive for COVID-19 14 days after their first dose.
COVID-19 booster shots to start in September: Officials
August 18, 2021
Booster shots to ramp up protection against COVID-19 infection are slated to begin the week of Sept. 20, the Biden administration announced at a press briefing August 18.Those who received the Pfizer-BioNTech and Moderna vaccines ...
Latest data show increase in breakthrough COVID-19 cases
August 18, 2021
“Remember when the early vaccine studies came out, it was like nobody gets hospitalized, nobody dies. ... That clearly is not true.”
Fauci says ‘unprecedented’ conditions could influence COVID vaccine approval for kids
August 6, 2021
“If I were a [non-COVID] virus looking for a niche, I would be really confused,” Dr. Fauci told pediatric hospitalists.
Delta variant could drive herd immunity threshold over 80%
August 4, 2021
In addition to driving up case numbers, the Delta variant could also push the threshold to achieve herd immunity higher.
‘A few mutations away’: The threat of a vaccine-proof variant
July 30, 2021
“When we have lots of people infected, we give more chances to the virus to diversify and then adapt to selective pressures.”
New details of myocarditis linked to COVID vaccines
July 2, 2021
Further details from multiple cases of myocarditis linked to the Pfizer and Moderna mRNA COVID vaccines have been described in recent papers in the medical literature.
Few clinical guidelines exist for treating post-COVID symptoms
June 24, 2021
‘We can prevent many infections from this virus, but we are still left to manage many post-COVID symptoms,’ says Dr. Linda Girgis.
CDC director cites rise in hospitalizations in urging teen vaccinations
June 8, 2021
“Among hospitalized adolescents, nearly one-third required intensive care unit admission.”
CDC recommends use of Pfizer’s COVID vaccine in 12- to 15-year-olds
May 13, 2021
ACIP voted 14-0 in favor of the safety and effectiveness of the vaccine in younger teens.